Back to Results
First PageMeta Content



Press Release ImevaX secures EUR 7.5 million in Series A Financing to develop highly specific vaccine against Helicobacter pylori infections Munich (Germany), October 28, 2014: ImevaX GmbH, a specialist in vaccines agai
Add to Reading List

Document Date: 2014-10-28 05:44:28


Open Document

File Size: 106,79 KB

Share Result on Facebook
UPDATE